Brendan Hannah - Aug 19, 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CHIEF BUSINESS OFFICER AND COO
Signature
/s/ Brendan Hannah
Stock symbol
QNCX
Transactions as of
Aug 19, 2024
Transactions value $
$24,166
Form type
4
Date filed
8/21/2024, 06:38 PM
Previous filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $1.25K +2.16K +0.84% $0.58 260K Aug 19, 2024 Direct
transaction QNCX Common Stock Purchase $1.53K +2.5K +0.96% $0.61 262K Aug 20, 2024 Direct
transaction QNCX Common Stock Purchase $2.05K +3.42K +1.31% $0.60 266K Aug 20, 2024 Direct
transaction QNCX Common Stock Purchase $1.39K +2.28K +0.86% $0.61 268K Aug 21, 2024 Direct
transaction QNCX Common Stock Purchase $3.1K +5K +1.87% $0.62 273K Aug 21, 2024 Direct
transaction QNCX Common Stock Purchase $14.8K +23.6K +8.63% $0.63 297K Aug 21, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.